The 16th edition of Dr. Agarwal’s Retina Foundation’s flagship scientific conference, Reticon 2026, convened today, drawing over 1000 participants, including vitreoretinal specialists, general ophthalmologists, clinicians, researchers, and ophthalmology postgraduates from across India and internationally. This one-day event focused on the latest scientific advancements in the diagnosis and management of vitreoretinal disorders. It provided an in-depth exploration of emerging techniques and technologies in retina care, fostering an environment of collaborative knowledge-sharing and scientific exchange.
Prof. Dr. C Sridhar, MD, Hon’ble Vice Chancellor of Meenakshi Academy of Higher Education and Research, inaugurated Reticon 2026 in the presence of Prof. Dr. Amar Agarwal, Chairman; Dr. Ashvin Agarwal, Chief Clinical Officer, and Dr. Manoj Khatri, Director, Vitreo-Retinal Services, Dr. Agarwals Eye Hospital.
The conference featured around 50 eminent speakers from India and abroad, who shared their expertise through a comprehensive scientific program encompassing both medical and surgical retina. Key sessions focused on emerging trends in retina care, advancements in treatments for retinal vascular diseases, and surgical retina techniques, providing delegates with valuable insights into the latest updates in clinical practice.
Hands-on learning was a major attraction through dedicated Wet Lab sessions focusing on advanced vitreoretinal surgical techniques and skill development, including Glued IOL, SFT, and Intravitreal Injections. Other highlights included expert discussions and debates, where specialists deliberated on important topics in retina care. Panel discussions and interactive sessions were also expected to provide participants with practical insights into the evolving field of vitreoretinal treatment.
In his remarks, Prof. Amar Agarwal stated, “We take great pride in organizing Reticon year after year and witnessing its evolution into a distinguished platform for retina specialists, educators, and researchers worldwide. Reticon embodies this vision by uniting top minds to share knowledge and foster innovation. With a distinguished lineup of speakers and thousands of participants, this conference provides a unique opportunity for vitreoretinal specialists, fellows, postgraduates, and general ophthalmologists to explore the latest advancements in techniques, technologies, and treatment strategies. Our goal is to empower clinicians to improve patient outcomes through ongoing education and global collaboration.”
Dr Manoj Khatri, Organising Secretary, Reticon 2026, said: “Diseases affecting the retina and vitreous are among the most significant causes of vision loss, making timely diagnosis, advanced treatment, and continuous clinical upskilling extremely important. Reticon 2026 has been designed to disseminate the latest knowledge and practical advancements in this rapidly evolving super specialty, enabling ophthalmologists to deliver better outcomes for patients.” He further added “The conference highlights include focused sessions on medical retina, surgical retina, wet labs, debates, panel discussions, and the Reticon Premier League, creating a dynamic platform for learning and interaction. By equipping healthcare professionals with current techniques, emerging technologies, and evidence-based approaches, we hope to strengthen retina care across India and beyond.”